This is a community-generated profile. If you would like to claim it, please .
Intrexon Funding
$0
77 rounds
Intrexon is active in the following markets / industries: biotechnology. The company has secured funding across 7 rounds and is valued at $0. Their most recent funding was raised on August 8, 2013.
Funding Rounds
IPO
$160000000U
$150000000U
$100000000UnknownMay 2011
C
$10000000C
$25000000Series CMay 2007
U
$1000000UnknownMar 2006
B
$500000Series BMay 2005
Investors of Intrexon
Founder/Managing Partner of Hunt Technology Ventures, L.P. / Early stage investor backing relentless founders with disruptive ideas.
Steven Kellman
B.A. Gabelli School of Business, former Analyst from Goldman Sachs, Current Investor at BlueBay Asset Management and a avid world traveler
Kyle DiFiore
Background in Real Estate investing (commercial). Have always had interest in technologies and bio science
NewVa Capital Partners
Rounds
U
U
Third Security
Rounds
U
C
B
Acquisitions of Intrexon
immunologix
Exit